Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction

Background Older adults presenting with acute myocardial infarction (MI) often have multivessel coronary artery disease amenable to percutaneous coronary intervention (PCI), yet the risks of multivessel intervention may outweigh potential benefits in these patients. We sought to determine if nonculprit intervention during the index PCI is associated with better outcomes among older patients with acute MI and multivessel disease. Methods We examined 19,271 ST-segment elevation MI (STEMI) and 31,361 non-STEMI (NSTEMI) patients 65 years or older with multivessel disease in a linked CathPCI Registry-Medicare database, excluding patients with prior coronary artery bypass grafting, left main disease, or cardiogenic shock. Using inverse probability-weighted propensity adjustment, we compared mortality between patients receiving culprit-only vs multivessel intervention during the index PCI procedure. Results Most older MI patients (91% STEMI and 74% NSTEMI) received culprit-only intervention during the index PCI. Among STEMI patients, multivessel intervention during the index PCI was associated with higher 30-day mortality (8.3% vs 6.3%, adjusted hazard ratio [HR] 1.36, 95% CI 1.14-1.62) than culprit-only intervention, and this trend persisted at 1 year (13.8% vs 12.2%, adjusted HR 1.14, 95% CI 0.99-1.31). No significantmortality differences were observed among NSTEMI patients at 30 days (3.4% vs 4.1%, adjusted HR 1.01, 95% CI 0.88-1.15) or at 1 year (10.1% vs 10.8%, adjusted HR 0.99, 95% CI 0.91-1.08). Conclusions Nonculprit intervention during the index PCI was associated with worse outcomes among STEMI patients, but not NSTEMI patients.